These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2156487)

  • 21. Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection.
    Gold D; Ashley R; Handsfield HH; Verdon M; Leach L; Mills J; Drew L; Corey L
    J Infect Dis; 1988 Feb; 157(2):319-26. PubMed ID: 2826612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing antibody response to cytomegalovirus in seropositive pregnant women.
    Tanaka A; Moriuchi H; Hirota K; Numazaki Y
    J Med Virol; 1991 Jun; 34(2):85-8. PubMed ID: 1653821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The guinea pig cytomegalovirus model of congenital human cytomegalovirus infection.
    Bia FJ; Miller SA; Davidson KH
    Birth Defects Orig Artic Ser; 1984; 20(1):233-41. PubMed ID: 6329364
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice.
    Farrell HE; Shellam GR
    J Gen Virol; 1989 Oct; 70 ( Pt 10)():2573-86. PubMed ID: 2552004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination for the prevention of maternal and fetal infection with guinea pig cytomegalovirus.
    Bia FJ; Griffith BP; Tarsio M; Hsiung GD
    J Infect Dis; 1980 Nov; 142(5):732-8. PubMed ID: 6257798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus infection in guinea pigs. II. Transplacental and horizontal transmission.
    Choi YC; Hsiung GD
    J Infect Dis; 1978 Aug; 138(2):197-202. PubMed ID: 210239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural vs vaccine-acquired immunity to cytomegalovirus.
    Plotkin SA
    JAMA; 2003 Oct; 290(13):1709; author reply 1709. PubMed ID: 14519704
    [No Abstract]   [Full Text] [Related]  

  • 28. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
    Schleiss MR; Stroup G; Pogorzelski K; McGregor A
    Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
    Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
    Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta.
    Hashimoto K; Yamada S; Katano H; Fukuchi S; Sato Y; Kato M; Yamaguchi T; Moriishi K; Inoue N
    Vaccine; 2013 Jun; 31(31):3199-205. PubMed ID: 23684839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Humoral immune response to unique structural proteins of human cytomegalovirus. Prospects of using antibodies detected by immunoblotting in the serological diagnosis of cytomegalovirus infections].
    Landini MP
    Recenti Prog Med; 1988 Oct; 79(10):430-40. PubMed ID: 2854651
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed amplification of cytomegalovirus infection in the placenta and maternal tissues during late gestation.
    Goff E; Griffith BP; Booss J
    Am J Obstet Gynecol; 1987 May; 156(5):1265-70. PubMed ID: 3034060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal cell-mediated cytolysis of CMV-infected fetal cells and the outcome of pregnancy in the guinea pig.
    Harrison CJ; Myers MG
    J Med Virol; 1989 Jan; 27(1):66-71. PubMed ID: 2537877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid increase in the serum Cytomegalovirus IgG avidity index in women with a congenitally infected fetus.
    Ebina Y; Minematsu T; Morioka I; Deguchi M; Tairaku S; Tanimura K; Sonoyama A; Nagamata S; Morizane M; Yamada H
    J Clin Virol; 2015 May; 66():44-7. PubMed ID: 25866335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to guinea pig cytomegalovirus polypeptides and cross reactivity with human cytomegalovirus.
    Kacica MA; Harrison CJ; Myers MG; Bernstein DI
    J Med Virol; 1990 Nov; 32(3):155-9. PubMed ID: 2177780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model.
    Olejniczak MJ; Choi KY; McVoy MA; Cui X; Schleiss MR
    Virol J; 2011 Mar; 8():89. PubMed ID: 21371319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic and prognostic value of specific immune response to Cytomegaloviruses in pregnant women with a history of habitual abortion].
    Sukhikh GT; Dadal'ian LG; Van'ko LV; Kalafati TI; Sidel'nikova VM
    Akush Ginekol (Mosk); 1992; (3-7):30-3. PubMed ID: 1336320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The course of anti-cytomegalovirus antibodies during pregnancy].
    Panà A; Santi AL; Divizia M; Vescia N
    Nuovi Ann Ig Microbiol; 1979; 30(5):321-9. PubMed ID: 233381
    [No Abstract]   [Full Text] [Related]  

  • 39. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
    Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
    J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of human cytomegalovirus-specific T cells during pregnancy determined by intracellular cytokine staining.
    Fujikawa T; Numazaki K; Asanuma H; Kudo R; Tsutsumi H
    J Med Virol; 2003 Dec; 71(4):527-31. PubMed ID: 14556265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.